Abstract: As a promising technology in the B5G and 6 G era, integrated sensing and communication (ISAC) can simultaneously support high-quality sensing and communication, and there is a growing ...

Abstract: This article examines the application system of multi-objective optimization algorithm in resource allocation, to enhance the fairness and efficiency of resource allocation. Resource ...

Lundbeck announces last patient randomized ahead-of-schedule in phase 3 MASCOT clinical trial: Valby, Denmark Wednesday, March 11, 2026, 13:00 Hrs [IST] H. Lundbeck A/S (Lundbeck) ...

The last patient in Lundbeck’s phase 3 clinical trial, MASCOT, has been randomised ahead of schedule in a study evaluating amlenetug as a potential treatment for multiple system atrophy (MSA). The ...

Clinical-stage biotech Alterity Therapeutics has appointed internationally recognised neurologist Dr Daniel O Claassen as Chief Medical Advisor as it advances its lead drug candidate ATH434 toward a ...

Shares of Theravance Biopharma TBPH plunged 26% after the company announced the failure of the late-stage CYPRESS study ...

Company is advancing ATH434 in late-stage clinical development for Multiple System Atrophy, a rapidly progressive neurodegenerative disease ...

There is no evidence that Chicago police brass updated Mayor Brandon Johnson and three City Council committee chairs about their progress in crafting a system designed to alert officials about which ...

A student-run organization at the University of Missouri, Rockin’ Against Multiple Sclerosis, is hosting philanthropic events to raise money for the Multiple Sclerosis Institute while leaving a ...